HEADER PROTEIN BINDING 25-NOV-09 2KQZ TITLE SOLUTION STRUCTURE OF THE RPN13 DEUBAD DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASOMAL UBIQUITIN RECEPTOR ADRM1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ADHESION-REGULATING MOLECULE 1, ARM-1, 110 KDA CELL MEMBRANE COMPND 5 GLYCOPROTEIN, GP110, RPN13 HOMOLOG, PROTEASOME REGULATORY PARTICLE COMPND 6 NON-ATPASE 13, HRPN13; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADRM1, GP110; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX4T1; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PLASMID KEYWDS PROTEASOME, UCH37-BINDING DOMAIN, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 35 AUTHOR X.CHEN,B.LEE,D.FINLEY,K.J.WALTERS REVDAT 2 23-DEC-15 2KQZ 1 TITLE VERSN REVDAT 1 26-MAY-10 2KQZ 0 JRNL AUTH X.CHEN,B.H.LEE,D.FINLEY,K.J.WALTERS JRNL TITL STRUCTURE OF PROTEASOME UBIQUITIN RECEPTOR HRPN13 AND ITS JRNL TITL 2 ACTIVATION BY THE SCAFFOLDING PROTEIN HRPN2. JRNL REF MOL.CELL V. 38 404 2010 JRNL REFN ISSN 1097-2765 JRNL PMID 20471946 JRNL DOI 10.1016/J.MOLCEL.2010.04.019 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR_NIH 2.24 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE STRUCTURES ARE BASED ON A TOTAL OF REMARK 3 2721 RESTRAINTS, 2503 ARE NOE-DERIVED DISTANCE CONSTRAINTS, 76 REMARK 3 DISTANCE RESTRAINTS FROM HYDROGEN BONDS, 142 DIHEDRAL ANGLE REMARK 3 RESTRAINTS. REMARK 4 REMARK 4 2KQZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-DEC-09. REMARK 100 THE RCSB ID CODE IS RCSB101464. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 20 MM PHOSPHATE, 50 MM NACL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.7 MM [U-100% 13C; U-100% 15N; REMARK 210 U-70% 2H] XCCD, 0.7 MM [U-15N; U- REMARK 210 50% 2H] XCCD, 0.7 MM [U-15N; 100% REMARK 210 2H] XCCD, 0.5 MM [U-15N] XCCD, REMARK 210 1.0 MM XCCD, 90% H2O/10% D2O; 0.7 REMARK 210 MM [U-13C] XCCD, 100% D2O; 1.0 MM REMARK 210 XCCD, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCA; 3D REMARK 210 HN(CO)CA; 3D HNCO; 3D HCCH-TOCSY; REMARK 210 3D HNCACB; 2D 1H-1H NOESY; 2D 1H- REMARK 210 13C HSQC; 3D 1H-13C NOESY; 3D 1H- REMARK 210 15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMRJ, NMRPIPE 2.5, XEASY 6.4, REMARK 210 CARA 1.8.4, X-PLOR_NIH 2.24 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 35 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 35 REMARK 210 CONFORMERS, SELECTION CRITERIA : ALL CALCULATED STRUCTURES REMARK 210 SUBMITTED REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 254 -70.73 -149.79 REMARK 500 1 ALA A 255 -31.26 -172.20 REMARK 500 1 ALA A 256 -50.48 -155.68 REMARK 500 1 ILE A 262 -165.86 -129.35 REMARK 500 1 GLN A 263 -75.86 56.93 REMARK 500 1 MET A 274 57.50 -98.99 REMARK 500 1 VAL A 276 73.59 40.53 REMARK 500 1 ALA A 278 150.03 61.83 REMARK 500 1 PRO A 280 83.28 -45.42 REMARK 500 1 THR A 293 152.74 -43.82 REMARK 500 1 PRO A 315 19.97 -68.79 REMARK 500 1 SER A 316 108.66 71.39 REMARK 500 1 PRO A 321 -138.11 -47.39 REMARK 500 1 GLN A 322 -69.97 -141.99 REMARK 500 1 THR A 330 -77.16 -142.72 REMARK 500 1 SER A 333 -36.02 161.22 REMARK 500 1 LEU A 361 152.97 -47.58 REMARK 500 1 PRO A 362 144.33 -39.50 REMARK 500 1 GLU A 388 30.66 -178.11 REMARK 500 1 THR A 394 85.10 -165.54 REMARK 500 1 LYS A 395 65.94 -100.13 REMARK 500 1 ASP A 399 -47.42 -166.28 REMARK 500 1 GLU A 400 75.03 43.75 REMARK 500 2 THR A 254 -43.79 -145.23 REMARK 500 2 SER A 257 66.39 -171.28 REMARK 500 2 THR A 259 59.71 -159.13 REMARK 500 2 SER A 265 -35.39 -168.52 REMARK 500 2 LEU A 271 40.05 -73.82 REMARK 500 2 ALA A 272 -41.33 -143.86 REMARK 500 2 ASN A 275 97.61 63.51 REMARK 500 2 VAL A 276 75.40 31.75 REMARK 500 2 ALA A 281 -82.19 55.51 REMARK 500 2 THR A 293 156.03 -45.37 REMARK 500 2 PRO A 315 22.34 -71.48 REMARK 500 2 SER A 316 97.61 60.99 REMARK 500 2 SER A 319 -163.78 -161.90 REMARK 500 2 PRO A 321 -137.18 -49.60 REMARK 500 2 GLN A 322 -56.30 -148.10 REMARK 500 2 THR A 330 -76.80 -146.93 REMARK 500 2 SER A 333 -42.46 166.98 REMARK 500 2 MET A 356 -15.91 -46.15 REMARK 500 2 GLN A 389 26.80 38.71 REMARK 500 2 LYS A 395 82.62 44.13 REMARK 500 2 LYS A 397 -92.54 -85.14 REMARK 500 2 LYS A 398 99.08 -60.67 REMARK 500 2 ASP A 399 118.91 -161.21 REMARK 500 2 GLU A 402 165.39 55.44 REMARK 500 2 ASP A 403 -44.22 -136.39 REMARK 500 2 SER A 405 -13.79 -152.93 REMARK 500 3 THR A 254 -8.49 -59.10 REMARK 500 REMARK 500 THIS ENTRY HAS 990 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR DETERMINED REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2R2Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PROTEASOMAL RPN13 PRU-DOMAIN REMARK 900 RELATED ID: 2Z4D RELATED DB: PDB REMARK 900 NMR STRUCTURES OF YEAST PROTEASOME COMPONENT RPN13 REMARK 900 RELATED ID: 2Z59 RELATED DB: PDB REMARK 900 COMPLEX STRUCTURES OF MOUSE RPN13 (22-130AA) AND UBIQUITIN REMARK 900 RELATED ID: 3IHR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UCH37 DBREF 2KQZ A 253 407 UNP Q16186 ADRM1_HUMAN 253 407 SEQRES 1 A 155 SER THR ALA ALA SER PRO THR GLN PRO ILE GLN LEU SER SEQRES 2 A 155 ASP LEU GLN SER ILE LEU ALA THR MET ASN VAL PRO ALA SEQRES 3 A 155 GLY PRO ALA GLY GLY GLN GLN VAL ASP LEU ALA SER VAL SEQRES 4 A 155 LEU THR PRO GLU ILE MET ALA PRO ILE LEU ALA ASN ALA SEQRES 5 A 155 ASP VAL GLN GLU ARG LEU LEU PRO TYR LEU PRO SER GLY SEQRES 6 A 155 GLU SER LEU PRO GLN THR ALA ASP GLU ILE GLN ASN THR SEQRES 7 A 155 LEU THR SER PRO GLN PHE GLN GLN ALA LEU GLY MET PHE SEQRES 8 A 155 SER ALA ALA LEU ALA SER GLY GLN LEU GLY PRO LEU MET SEQRES 9 A 155 CYS GLN PHE GLY LEU PRO ALA GLU ALA VAL GLU ALA ALA SEQRES 10 A 155 ASN LYS GLY ASP VAL GLU ALA PHE ALA LYS ALA MET GLN SEQRES 11 A 155 ASN ASN ALA LYS PRO GLU GLN LYS GLU GLY ASP THR LYS SEQRES 12 A 155 ASP LYS LYS ASP GLU GLU GLU ASP MET SER LEU ASP HELIX 1 1 SER A 265 MET A 274 1 10 HELIX 2 2 GLN A 284 LEU A 292 1 9 HELIX 3 3 MET A 297 ASN A 303 1 7 HELIX 4 4 ASN A 303 LEU A 314 1 12 HELIX 5 5 THR A 323 ASN A 329 1 7 HELIX 6 6 SER A 333 SER A 349 1 17 HELIX 7 7 LEU A 352 PHE A 359 1 8 HELIX 8 8 PRO A 362 GLY A 372 1 11 HELIX 9 9 ASP A 373 ALA A 385 1 13 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 MODEL 2 MODEL 3 MODEL 4 MODEL 5 MODEL 6 MODEL 7 MODEL 8 MODEL 9 MODEL 10 MODEL 11 MODEL 12 MODEL 13 MODEL 14 MODEL 15 MODEL 16 MODEL 17 MODEL 18 MODEL 19 MODEL 20 MODEL 21 MODEL 22 MODEL 23 MODEL 24 MODEL 25 MODEL 26 MODEL 27 MODEL 28 MODEL 29 MODEL 30 MODEL 31 MODEL 32 MODEL 33 MODEL 34 MODEL 35